Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AstraZeneca Faces Investigation by Chinese Authorities

December 12, 2024
AstraZeneca PLC (AZN) shares experienced a decline in value following reports of a probe by the People's Republic of China (PRC). The investigation is centered around alleged fraud and corruption within the company. The news has disappointed investors and raised concerns about AstraZeneca's operations in China. With 86% ownership of the shares, AstraZeneca is heavily controlled by institutional owners. Investors are recommended to seek guidance from professionals at Stocks Prognosis to determine the future movement of the company's shares.
If you want to leave a comment, then you need Login or Register





Other data for AZN

Related data

AZNJune 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know  ~1 min.

AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....

AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....

AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....

AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....

AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....

AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....

AZNMarch 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy  ~2 min.

ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....

AZNFebruary 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential  ~2 min.

AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....

AZNFebruary 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....

AZNFebruary 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial  ~2 min.

AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....

AZNDecember 10, 2024AstraZeneca PLC: A Leading Pharmaceutical Company with Strong Momentum  ~2 min.

AstraZeneca PLC (AZN) is a renowned pharmaceutical company that has been experiencing strong momentum in the market....

AZNDecember 13, 2024Hagens Berman Advisory Resource Group Makes New $946,000 Investment in AstraZeneca PLC  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently received a significant investment from Hagens Berman Advisory Resource Group in the amount of $946,000....

AZNDecember 21, 2024AstraZeneca Faces Investigation by Chinese Regulator, Shares Decline  ~1 min.

AstraZeneca PLC (AZN) shares have experienced a significant drop after reports emerged of a probe by the People's Republic of China (PRC) regarding alleged fraud and corruption....

AZNNovember 10, 2024AstraZeneca PLC AZN: A Company on the Rise, Stocks Prognosis Recommends Buying  ~2 min.

AstraZeneca PLC (AZN), a global biopharmaceutical company, is steadily climbing the success ladder, and Stocks Prognosis recommends taking advantage of this upward trend by investing in their stocks....

AZNNovember 4, 2024AstraZeneca Announces Share Capital Details - Stocks Prognosis Recommends Buying AZN Shares  ~2 min.

AstraZeneca PLC, a renowned pharmaceutical company, recently revealed its share capital details. This news has attracted the attention of investors worldwide....